Tracking muscle changes with wearable sensors during vyvgart treatment for myasthenia gravis
Part of Brain & nervous system, Cancer, Immune system & allergy clinical trials.
This study uses small wearable sensors and a smartphone app (the BioDigit MG system) to track changes in muscle strength and daily activity over time in people starting VYVGART for generalized myasthenia gravis. It aims to see if this digital tool can accurately measure how well the treatment works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have generalized myasthenia gravis (gMG) with symptoms affecting more than just eye muscles.
- Your muscle weakness is moderate to severe, but not at the level of a crisis.
- You are about to start treatment with VYVGART or VYVGART Hytrulo.
- You can walk at least 10 meters (about 33 feet) on your own, with or without a walker or cane.
- You don't need help with basic daily activities like dressing or eating.
- You can read and speak English fluently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses wearable sensors to track symptoms of myasthenia gravis in daily life. The goal is to see if these devices can better monitor how the disease changes over time.
This trial is testing a new way to track your generalized myasthenia gravis (gMG) using a smartphone app and a wearable activity monitor. It’s not testing a drug – it’s about improving how doctors monitor your condition remotely, which might help you better manage your symptoms.
This study uses lab-grown mini muscle-nerve cells (organoids) to better understand severe, hard-to-treat myasthenia gravis. It may help researchers find new treatment options for people with the AChR antibody type.
This study tests whether remote monitoring through smartphone apps can effectively track myasthenia gravis symptoms and help manage care from home, instead of frequent in-person visits.
This study tests a smartphone-based digital tool that helps check symptoms in people with generalized myasthenia gravis (MG). It may help patients and clinicians track how the disease is doing over time using simpler, repeated assessments.
This study uses your smartphone to record symptoms like slurred speech, hoarseness, arm fatigue, or droopy eyelids, making it easier for doctors to understand and monitor myasthenia gravis. Both people with MG and healthy volunteers can take part.
Hear when a new Myasthenia Gravis Generalized trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.